Search Results 171-180 of 12285 for fibrosis quistica
Mayo Clinic specialists are advancing ILD care through genetic testing for familial pulmonary fibrosis, inherited risk assessment and emerging antifibrotic ...
... fibrosis bronchiectasis with eosinophilic inflammation (NCFB+EI). All patients who complete the 52-week double-blind treatment period on investigational ...
Lebwohl MG, et al. Nephrogenic systemic fibrosis. In: Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 5th ed.
The purpose of this study is to evaluate the effectiveness and safety of bexotegrast (PLN-74809) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF) ...
This is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF) who are at high risk of adverse ...
... fibrosis (IPF). Specific objectives and corresponding endpoints for the study are outlined below. Participation eligibility. Participant eligibility includes ...
Clinical Trials · A Study to Determine if Oral Glucose Tolerance Testing can Improve Screening Compliance in Cystic Fibrosis · More about research at Mayo Clinic.
Fibrosing mediastinitis (FM) represents a fibroinflammatory disease involving the mediastinum and hilar areas. It is characterized by expansive growth of ...
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult ...
About this study. The purpose of this study is to investigate expression of LKB1 in exosomes in urine and plasma of kidney transplant recipients and define ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.